{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:52:23Z","timestamp":1795139543764,"version":"4.10.3"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,27]]},"abstract":"<jats:p>\n                    This study explores the factors influencing the persistence of cavities in patients with rifampicin-sensitive pulmonary tuberculosis who have completed outpatient follow-up treatment based on multiple regression analysis. A total of 218 rifampicin-sensitive pulmonary tuberculosis patients with pulmonary cavities, who were followed up at our hospital from January 2022 to October 2023, were selected as the study subjects. General patient data were collected, including gender, age, residence, smoking status, hemoptysis symptoms, presence of diabetes, initial treatment\/retreatment, number of outpatient visits, duration of intensive treatment, presence of extrapulmonary tuberculosis, and presence of chronic aspergillosis. Based on a reexamination of chest CT scans to evaluate lung cavity absorption after completion of treatment, patients were categorized into the cavity closure group or cavity persistence group. Multivariate logistic regression analysis was conducted to identify factors influencing cavity persistence, and a forest plot was generated. Among the 218 rifampicin-sensitive pulmonary tuberculosis patients, 55 (25.23%) had persistent pulmonary cavities. Multivariate logistic regression analysis revealed that smoking (OR\u2005=\u20052.209, 95% CI\u2005=\u20051.029\u20134.739,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.042), diabetes (OR\u2005=\u20053.423, 95% CI\u2005=\u20051.602\u20137.315,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001), retreatment (OR\u2005=\u20055.286, 95% CI\u2005=\u20051.983\u201314.087,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and chronic pulmonary aspergillosis (OR\u2005=\u20055.684, 95% CI\u2005=\u20052.459\u201313.138,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) were significant factors influencing the persistence of cavities (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Smoking, diabetes, retreatment of pulmonary tuberculosis, and chronic pulmonary aspergillosis are all factors that influence the persistence of cavities in patients with rifampicin-sensitive pulmonary tuberculosis who have completed treatment in outpatient clinics. Early intervention should be implemented in these cases.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043089","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:01:33Z","timestamp":1751295693000},"page":"e43089","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the influencing factors of cavities persist in rifampicin-sensitive pulmonary tuberculosis patients who have completed outpatient treatment based on logistic regression forest plot"],"prefix":"10.1097","volume":"104","author":[{"given":"Shan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Tuberculosis, Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Traditional Chinese Medicine, Lishui Tuberculosis Clinical Medical Research Center, Lishui, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-Rong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Traditional Chinese Medicine, Lishui Tuberculosis Clinical Medical Research Center, Lishui, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8512-3590","authenticated-orcid":false,"given":"Yin-Ping","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Traditional Chinese Medicine, Lishui Tuberculosis Clinical Medical Research Center, Lishui, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Qing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Traditional Chinese Medicine, Lishui Tuberculosis Clinical Medical Research Center, Lishui, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260813","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/trstmh\/trv108","article-title":"The WHO\u2019s new end TB strategy in the post-2015 era of the sustainable development goals.","volume":"110","author":"L\u00f6nnroth","year":"2016","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"346","DOI":"10.21037\/atm.2020.02.104","article-title":"Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis.","volume":"8","author":"Lee","year":"2020","journal-title":"Ann Transl Med"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","article-title":"Cavitary tuberculosis:the gateway of disease transmission.","volume":"20","author":"Urbanowski","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R5-20260813","first-page":"1059","article-title":"The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse.","volume":"12","author":"Hamilton","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.TNMI7-0032-2016","article-title":"Pulmonary tuberculosis.","volume":"5","author":"Lyon","year":"2017","journal-title":"Microbiol Spectr"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejrad.2004.03.009","article-title":"Radiological manifestations of pulmonary tuberculosis.","volume":"51","author":"Andreu","year":"2004","journal-title":"Eur J Radiol"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.201311-2106PP","article-title":"Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.","volume":"190","author":"Ong","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"3000605211035889","DOI":"10.1177\/03000605211035889","article-title":"Transbronchial tuberculosis cavity plugging therapy for pulmonary tuberculosis.","volume":"49","author":"Han","year":"2021","journal-title":"J Int Med Res"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.","volume":"360","author":"Benator","year":"2002","journal-title":"Lancet"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw566","article-title":"Executive summary: official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis.","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/CMR.00060-07","article-title":"Cavitary pulmonary disease.","volume":"21","author":"Gadkowski","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis.","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R14-20260813","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2249.2003.02121.x","article-title":"T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.","volume":"132","author":"Mazzarella","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"R15-20260813","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3390\/jpm11111081","article-title":"Clinical factors associated with cavitary tuberculosis and its treatment outcomes.","volume":"11","author":"Kim","year":"2021","journal-title":"J Pers Med"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"e93397","DOI":"10.1371\/journal.pone.0093397","article-title":"Glycemic control and radiographic manifestations of tuberculosis in diabetic patients.","volume":"9","author":"Chiang","year":"2014","journal-title":"PLoS One"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.5588\/ijtld.18.0657","article-title":"Tuberculosis and diabetes mellitus: a dose-response relationship between the odds of tuberculosis and HbA1c.","volume":"23","author":"Viney","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"6196532","DOI":"10.1155\/2019\/6196532","article-title":"Immunological Impacts of diabetes on the susceptibility of mycobacterium tuberculosis.","volume":"2019","author":"Ayelign","year":"2019","journal-title":"J Immunol Res"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"1250001","DOI":"10.3389\/fendo.2023.1250001","article-title":"Impact of diabetes itself and glycemic control status on tuberculosis.","volume":"14","author":"Meng","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R20-20260813","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1183\/09031936.00114214","article-title":"Smoking adversely affects treatment response, outcome and relapse in tuberculosis.","volume":"45","author":"Leung","year":"2015","journal-title":"Eur Respir J"},{"key":"R21-20260813","first-page":"003249","article-title":"Concomitant pulmonary tuberculosis and invasive aspergillosis infection in an immunocompetent host.","volume":"9","author":"Ahmed","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"R22-20260813","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-0043-1776914","article-title":"Chronic pulmonary aspergillosis: clinical presentation and management.","volume":"45","author":"Evans","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"R23-20260813","first-page":"683","article-title":"Tuberculosis status and coinfection of pulmonary fungal infections in patients referred to reference laboratory of health centers Ghaemshahr City during 2007\u20132017.","volume":"28","author":"Amiri","year":"2018","journal-title":"Ethiop J Health Sci"},{"key":"R24-20260813","first-page":"2692","article-title":"Clinical features and risk factors of pulmonary tuberculosis complicated with pulmonary aspergillosis.","volume":"26","author":"Teng","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R25-20260813","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.","volume":"89","author":"Denning","year":"2011","journal-title":"Bull World Health Organ"},{"key":"R26-20260813","doi-asserted-by":"crossref","first-page":"e2427266","DOI":"10.1001\/jamanetworkopen.2024.27266","article-title":"Recurrent pulmonary tuberculosis in China, 2005 to 2021.","volume":"7","author":"Li","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R27-20260813","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/thoraxjnl-2020-215449","article-title":"Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections.","volume":"76","author":"Vega","year":"2021","journal-title":"Thorax"},{"key":"R28-20260813","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.cmi.2022.05.019","article-title":"Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing.","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"R29-20260813","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5588\/ijtld.21.0185","article-title":"Chronic pulmonary aspergillosis as a sequel to pulmonary TB.","volume":"25","author":"Salzer","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"R30-20260813","doi-asserted-by":"crossref","first-page":"e13747","DOI":"10.1111\/myc.13747","article-title":"Chronic pulmonary aspergillosis incidence in newly detected pulmonary tuberculosis cases during follow-up.","volume":"67","author":"Jha","year":"2024","journal-title":"Mycoses"},{"key":"R31-20260813","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0043-1776913","article-title":"Chronic pulmonary aspergillosis as a considerable complication in post-tuberculosis lung disease.","volume":"45","author":"Neub\u00f6ck","year":"2024","journal-title":"Semin Respir Crit Care Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:06:28Z","timestamp":1786633588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":30,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043089","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}